Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/56836
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNicholls S.J.-
dc.coverage.spatialMonash Medical Centre-
dc.date.accessioned2025-12-23T22:38:50Z-
dc.date.available2025-12-23T22:38:50Z-
dc.date.issued2020-11-06-
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/56836-
dc.description.abstractThis study will be a placebo-controlled, double-blind, randomised Phase 2b/3 study in participants with established cardiovascular disease to evaluate the impact of statin therapy on changes in plaque burden and composition in participants with different polygenic risk scores using CT coronary angiogram. The study will take place at ten sites in Australia.-
dc.titleDo stAtins faVourably modify atherosclerotIc plaque in patients with differeNt levels of polygenic Cardiovascular (CV) rIsk?-
dc.typeClinical trial-
dc.description.publicationstatusNot Applicable-
dc.identifier.urlhttps://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=380177-
dc.identifier.externalACTRN12620001166965-
item.openairetypeClinical trial-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptCardiology (MonashHeart & Victorian Heart Institute)-
Appears in Collections:Clinical Trials
Show simple item record

Page view(s)

44
checked on May 23, 2026

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.